Headlands Technologies LLC Acquires 1,613 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Headlands Technologies LLC lifted its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 1,068.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,764 shares of the biopharmaceutical company’s stock after purchasing an additional 1,613 shares during the quarter. Headlands […]
More Stories
Synairgen (LON:SNG) Stock Price Down 0.9% – What’s Next?
Synairgen plc (LON:SNG – Get Free Report) shares fell 0.9% on Wednesday . The stock traded as low as GBX...
Victoria (LON:VCP) Trading Down 7.8% – Here’s What Happened
Victoria PLC (LON:VCP – Get Free Report) traded down 7.8% on Wednesday . The company traded as low as GBX...
Azincourt Energy (CVE:AAZ) Stock Price Up 50% – Still a Buy?
Shares of Azincourt Energy Corp. (CVE:AAZ – Get Free Report) shot up 50% during mid-day trading on Wednesday . The...
Genus (LON:GNS) Reaches New 1-Year Low – Time to Sell?
Genus plc (LON:GNS – Get Free Report)’s share price hit a new 52-week low on Wednesday . The stock traded...
Southern Empire Resources (CVE:SMP) Shares Up 50% – Time to Buy?
Southern Empire Resources Corp. (CVE:SMP – Get Free Report) shares were up 50% during trading on Wednesday . The stock...
Azincourt Energy (CVE:AAZ) Shares Up 50% – Still a Buy?
Azincourt Energy Corp. (CVE:AAZ – Get Free Report)’s share price shot up 50% during mid-day trading on Wednesday . The...